Australasian recurrent pregnancy loss clinical management guideline 2024, part II
Part II of the Australasian guideline for the investigation and management of recurrent pregnancy loss (RPL) provides evidence‐based guidance on the management of RPL provided. The implications of inherited and acquired thrombophilia with respect to RPL and suggestions for clinical management are pr...
Gespeichert in:
Veröffentlicht in: | Australian & New Zealand journal of obstetrics & gynaecology 2024-10, Vol.64 (5), p.445-458 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Part II of the Australasian guideline for the investigation and management of recurrent pregnancy loss (RPL) provides evidence‐based guidance on the management of RPL provided. The implications of inherited and acquired thrombophilia with respect to RPL and suggestions for clinical management are provided. Autoimmune factors, including human leukocyte antigen, cytokines, antinuclear antibodies and coeliac antibodies, and guidance for management are discussed. Infective, inflammatory and endometrial causes of RPL are discussed in detail. Environmental and lifestyle factors, male factor and unexplained causes are outlined. Levels of evidence and grades of consensus are provided for all evidence‐based statements. |
---|---|
ISSN: | 0004-8666 1479-828X 1479-828X |
DOI: | 10.1111/ajo.13820 |